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ABSTRACT
Humans are exposed to both endogenous and ex-
ogenous N-nitroso compounds (NOCs), and many
NOCs can be metabolically activated to generate a
highly reactive species, diazoacetate, which is
capable of inducing carboxymethylation of
nucleobases in DNA. Here we report, for the first
time, the chemical syntheses of authentic N
6-
carboxymethyl-20-deoxyadenosine (N
6-CMdA) and
N
4-carboxymethyl-20-deoxycytidine (N
4-CMdC),
liquid chromatography–ESI tandem MS confirmation
of their formation in calf thymus DNA upon
diazoacetate exposure, and the preparation of
oligodeoxyribonucleotides containing a site-
specifically incorporated N
6-CMdA or N
4-CMdC.
Additionally, thermodynamic studies showed that
the substitutions of a dA with N
6-CMdA and dC
with N
4-CMdC in a 12-mer duplex increased Gibbs
free energy for duplex formation at 25 C by 5.3 and
6.8kcal/mol, respectively. Moreover, primer exten-
sion assay revealed that N
4-CMdC was a stronger
blockade to Klenow fragment-mediated primer
extension than N
6-CMdA. The polymerase dis-
played substantial frequency of misincorporation
of dAMP opposite N
6-CMdA and, to a lesser
extent, misinsertion of dAMP and dTMP opposite
N
4-CMdC. The formation and the mutagenic
potential of N
6-CMdA and N
4-CMdC suggest
that these lesions may bear important implica-
tions in the etiology of NOC-induced tumor
development.
INTRODUCTION
Human genome is frequently attacked by various en-
dogenous and exogenous species, and the resulting
damage to DNA has been implicated in a number of
pathological conditions including cancer and neurological
disorders (1). Emerging data have supported a previous
hypothesis that DNA damage induced by N-nitroso com-
pounds (NOCs) in the gastric cavity may constitute the
early steps of carcinogenesis in gastric cancer due to the
high nitrite content of the gastric juice (2,3). In a recent
review, Risch (4) proposed that frequent gastrointestinal
exposure to NOCs contributes to increased risk of de-
veloping pancreatic cancer. In this respect, NOCs induce
DNA adducts and single-strand breaks (5), which appear
to stimulate DNA synthesis in the pancreatic ductal epi-
thelium (6). Thus, exposure to NOCs may work synergis-
tically with other factors to induce tumor development (7).
Humans are exposed to NOCs from diet, tobacco
smoke and other environmental sources as well as from
endogenous sources, and it was estimated that endogenous
sources contribute to 45–75% of the total NOC exposure
(3). Earlier studies by Wogan and colleagues (8) revealed
that the treatment of male Fischer rats with nitrosated bile
acid conjugates N-nitrosoglycocholic acid (NOGC) and
N-nitrosotaurocholic acid (NOTC) could induce
hepatocarcinoma in 54–70% of the treated animals and
gastric tumors in 12–13% of the treated rats. Forward
mutation assays showed that NOGC and NOTC are mu-
tagenic in bacteria cells and human lymphoblasts. In this
regard, NOGC could arise from the nitrosation of
glycocholic acid under simulated gastric conditions
(9,10). The treatment of calf thymus DNA with
NOGC could induce the formation of
O
6-carboxymethyl-20-deoxyguanosine (O
6-CMdG) and,
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6-methyl-20-deoxyguanosine
(O
6-MdG) (11). By using immunoslot blot assay or
immunoaﬃnity/HPLC method with antibody recognizing
O
6-carboxymethylguanine, Shuker and coworkers (12–14)
showed that O
6-CMdG could be induced in DNA by
N-nitrosoglycine. In addition, O-diazoacetyl-L-serine
(also known as azaserine), a pancreatic carcinogen (15),
could result in the carboxymethylation of guanine residues
in DNA of pancreatic acinar cells (16).
The NOC-induced DNA carboxymethylation was
thought to occur through a common reactive intermedi-
ate, diazoacetate, which was shown to induce the forma-
tion of O
6-CMdG and, much less eﬃciently (about 1/16 of
that of O
6-CMdG), O
6-MdG in DNA (12–14). In
addition, the passage of potassium diazoacetate (KDA)-
treated, human p53 gene-containing plasmid in yeast cells
could lead to substantial single-base substitutions.
Importantly, the mutation spectra of KDA obtained
from the shuttle vector study exhibit remarkable similarity
as the mutation spectra of p53 gene in human stomach and
colorectal cancers (17). This ﬁnding underscores that
gastrointestinal exposure to NOCs and the resulting gen-
eration of diazoacetate may constitute a signiﬁcant etio-
logical factor for the development of gastrointestinal
tumors (17). In addition, KDA induced almost equal
frequencies of transition and transversion mutations,
which is distinctive from the predominant GC!AT tran-
sition mutation (>80%) induced by methylating agent
methylnitrosourea (17). Moreover, the percentages of mu-
tations occurring at AT base pairs contribute to 43 and
28% of all observed mutations, while the p53 gene-
containing vector was treated with KDA in PBS and
Tris–EDTA, respectively. The above observation
supports that KDA can induce promutagenic lesions at
both GC and AT base pairs in DNA.
As discussed above, KDA was found to induce the for-
mation of O
6-CMdG and we recently reported the forma-
tion of N3- and O
4-carboxymethylthymidine in calf
thymus DNA upon exposure to KDA (18). However, it
remains unexplored what type of DNA lesions can be
induced at adenine and cytosine sites in DNA. In the
present study, we set out to examine the chemistry of
diazoacetate-induced modiﬁcations of adenine and
cytosine in DNA, and to synthesize oligodeoxyribonu-
cleotides (ODNs) containing carboxymethylated deriva-
tives of 20-deoxyadenosine and 20-deoxycytidine at
deﬁned sites. In addition, we will have a preliminary as-
sessment about how these lesions destabilize duplex DNA
and how they perturb DNA replication in vitro.
MATERIALS AND METHODS
Materials
Chemicals and reagents were purchased from
Sigma-Aldrich (St Louis, MO, USA) and Thermo Fisher
Scientiﬁc (Pittsburgh, PA, USA) unless otherwise
speciﬁed. Reagents for solid-phase DNA synthesis were
obtained from Glen Research Co. (Sterling, VA, USA)
and unmodiﬁed ODNs were from Integrated DNA
Technologies (Coralville, IA, USA). Calf intestinal
alkaline phosphatase and Klenow fragment (Kf
 ) were
purchased from US Biological (Swampscott, MA, USA)
and New England Biolabs (Beverly, MA, USA), respect-
ively. [g 
32P]ATP was obtained from Amersham
Biosciences Co. (Piscataway, NJ, USA).
Mass spectrometry and NMR
Electrospray ionization-mass spectrometry (ESI-MS) and
tandem MS (MS/MS) experiments were carried out on an
LCQ Deca XP ion-trap mass spectrometer (Thermo
Fisher Scientiﬁc, San Jose, CA, USA). A mixture of
methanol and water (50:50, v/v) was used as solvent for
electrospray. The spray voltage was 3.0kV, and the tem-
perature of the heated capillary was maintained at 300 C.
High-resolution mass spectra (HRMS) were acquired on
an Agilent 6210-TOF LC/MS instrument (Agilent
Technologies, Santa Clara, CA, USA) equipped with an
ESI source.
1H NMR spectra were recorded on Varian
Inova NMR spectrometers at 300 or 400MHz (Varian
Inc., Palo Alto, CA, USA) and
31P NMR spectra were
acquired at 80MHz. The H20 and H200 protons on nucleo-
sides were assigned based on coupling constant measure-
ments (19).
HPLC
HPLC experiments were performed on an Agilent 1100
HPLC System with an Apollo C18 column
(4.6 250mm, 5mm in particle size and 300A ˚ in pore
size; W. R. Grace & Co., Deerﬁeld, IL, USA). For the
puriﬁcation of ODNs, a triethylammonium acetate
buﬀer (50mM, pH 6.6, Solution A) and a mixture
(Solution B) of solution A and acetonitrile (70/30, v/v)
were employed as mobile phases. The ﬂow rate was
0.8ml/min and gradient proﬁles in terms of solution B
were as following: (Gradient I) 5min 0–20%, 40min
20–40%, 15min 40–100% and 5min at 100%; (Gradient
II) 5min 0–35%, 60min 35–50%, 10min 50–100% and
10min at 100%.
For the separation of nucleosides, an ammonium
formate buﬀer (10mM, pH 6.9, Solution A) and a
mixture of Solution A and acetonitrile (70/30, v/v,
Solution B) were served as mobile phases. The ﬂow rate
was 0.8ml/min and Gradient III used in this experiment
was 5min 0–10 % Solution B followed by 40min 10–40%
Solution B.
LC–MS/MS
Coupled liquid chromatography–ESI tandem MS (LC–
MS/MS) experiments were performed using an Agilent
1100 capillary HPLC pump and an LTQ linear ion trap
mass spectrometer (Thermo Fisher Scientiﬁc, San Jose,
CA, USA). A Zorbax SB-C18 column (0.5 150mm,
5mm in particle size; Agilent Technologies) was used,
and a 0.1% formic acid in water (Solution A) and a
0.1% formic acid in methanol (Solution B) were
employed as mobile phases. The ESI spray voltage was
3.0kV, and the temperature for the heated capillary was
maintained at 275 C.
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6-ethoxycarbonylmethyl-
20-deoxyadenosine (1a)
Compound 1a was synthesized according to previously
published procedures for the preparation of other
N
6-substituted 20-deoxyadenosine derivatives (Scheme 1a)
(20,21). Glycine ethyl ester was synthesized following pre-
viously published procedures (22,23). To a round bottom
ﬂask were added commercially available 6-chloro-9-
(2-deoxy-b-D-erythro-pentofuranosyl)purine (6-CldA,
70mg, 0.26mmol; Berry & Associates, Dexter, MI,
USA), glycine ethyl ester (132mg, 1.3mmol), triethylamine
(TEA) (209ml, 1.5mmol) and anhydrous acetonitrile
(5.0ml). The solution was stirred at room temperature
for 2 days and the solvent was removed in vacuo. Product
1a was isolated by silica gel column chromatography with
EtOAc and then EtOAc/MeOH (50/1, v/v) as mobile
phases. The product was obtained in white solid (48mg;
yield: 61%). HRMS (ESI): [M+H]
+ calcd m/z 338.1464,
found 338.1470.
1H NMR (400MHz, CDCl3,2 5  C;
Supplementary Figure S1): d 8.33 (s, 1H, H-8), 7.87
(s, 1H, H-2), 6.61 (broad, 1H, NH), 6.35 (t, 1H, H-10,
J=6.4Hz), 4.78 (m, 1H, H-30), 4.41 (broad, 2H, 30-OH
and 50-OH) 4.25 (m, 5H, H-40, NCH2 and OCH2), 3.95
(m, 1H, H-50), 3.81 (m, 1H, H-500), 3.05 (m, 1H, H-20),
2.33 (m, 1H, H-200), 1.30 (t, 3H, CH3, J=6.0Hz).
Synthesis of N
6-carboxymethyl-20-deoxyadenosine
(N
6-CMdA)
Compound 1a (20mg) was dissolved in 1.5ml metha-
nol and to the solution 1.0M NaOH (1.5ml) was added
(Scheme 1a). The mixture was stirred at room temperature
for 6h to complete the hydrolysis of the ethyl ester in 1a.
The solution was then neutralized with 1.0M HCl and the
solvent was removed in a Speed-vac to aﬀord light yellow
solid that was washed with CHCl3 (200ml 3) and ex-
tracted with methanol (500ml 4). The methanol layer
was combined and dried to render N
6-CMdA as a pale
yellow solid (16mg; yield: 87%). HRMS (ESI): [M+H]
+
calcd m/z 310.1151, found 310.1159.
1H NMR (400MHz,
D2O, 25 C; Supplementary Figure S2): d 8.15 (s, 1H, H-8),
8.06 (s, 1H, H-2), 6.33 (t, 1H, H-10, J=6.7Hz), 4.55 (m,
1H, H-30), 4.08 (s, 1H, H-40), 3.96 (broad, 2H, NCH2),
3.74 (m, 1H, H-50), 3.68 (m, 1H, H-500), 2.69 (m, 1H,
H-20), 2.49 (m, 2H, H-200).
Synthesis of 30,50-O-diacetyl-N
4-ethoxycarbonylmethyl-20-
deoxycytidine (2b)
Compound 2b was synthesized following previously
reported procedures for syntheses of relevant uridine
derivatives (Scheme 1b) (24,25). Compound 2a (181mg,
0.5mmol), prepared following previously described proto-
cols (26), glycine ethyl ester (102mg, 1.0mmol) and TEA
(167ml, 1.2mmol) were mixed in anhydrous acetonitrile
(10ml) in a round bottom ﬂask and the solution was
stirred at room temperature for 3 days. The solvent was
removed in vacuo and product 2b was isolated by silica gel
column chromatography by using EtOAc as mobile phase.
The product was obtained as yellowish oil (95mg; yield:
48%). HRMS (ESI): [M+H]
+ calcd m/z 398.1563, found
398.1571.
1H NMR (300MHz, CDCl3,2 5  C;
Supplementary Figure S3): d 7.66 (d, 1H, H-6,
J=6.0Hz), 6.28 (t, 1H, H-10, J=6.4Hz), 6.09 (broad,
1H, NH), 5.82 (d, 1H, H-5, J=6.0Hz), 5.17 (m, 1H,
H-30), 4.32 (m, 1H, H-40), 4.20 (m, 6H, NCH2, ethoxy
CH2, H-50 and H-500), 2.68 (m, 1H, H-200), 2.00 (m, 2H,
H-20), 2.05 (s, 3H, acetyl CH3), 2.06 (s, 3H, acetyl CH3),
1.27 (s, 3H, CH3).
Synthesis of N
4-carboxymethyl-20-deoxycytidine
(N
4-CMdC)
The method for the synthesis of N
6-CMdA was used with
slight modiﬁcation, where the hydrolysis of 2c was carried
N
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Scheme 1. Syntheses of authentic N
6-CMdA (a) and N
4-CMdC (b).
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hydroxyl groups (Scheme 1b). N
4-CMdC was obtained
as white solid (yield: 92%). HRMS (ESI): [M+H]
+ calcd
m/z 286.1039, found 286.1045.
1H NMR (300MHz, D2O,
25 C; Supplementary Figure S4): d 7.79 (d, 1H, H-6,
J=6.0Hz), 6.33 (t, 1H, H-10, J=6.7Hz), 6.13 (d, 1H,
H-5, J=6.0Hz), 4.48 (m, 1H, H-30), 4.10 (m, 1H, H-40),
3.86 (broad, 2H, NCH2), 3.87–3.80 (m, 2H, H-50 and
H-500), 2.50–2.30 (m, 2H, H-200 and H-20).
Synthesis of 50-O-(4,40-dimethoxytrityl)-N
6-
ethoxycarbonylmethyl-20-deoxyadenosine (1b)
Compound 1a (60mg) was dissolved in anhydrous pyridine
(3.0ml) and the solution was cooled in an ice bath. To the
solution were added 4-dimethylaminopyridine (DMAP,
0.5mg) and dimethoxytrityl chloride (DMTr-Cl, 72mg),
and the resulting solution was stirred at room temperature
for 90min (Scheme 2a). The reaction was then quenched
with methanol (0.1ml) and the solvent was removed under
reduced pressure. The product was isolated from the
reaction mixture on a silica gel column with the use of
EtOAc as mobile phase. The product was obtained as
yellow foam (88mg; yield: 77%). HRMS (ESI): [M+H]
+
calcd m/z 640.2771, found 640.2783.
1H NMR (400MHz,
DMSO-d6,2 5  C; Supplementary Figure S5): d 8.29 (s, 1H,
H-8), 8.15 (s, 1H, H-2), 7.32 (m, 5H, aromatic Hs),
7.21–7.19 (m, 5H, 4 aromatic Hs and NH), 6.81 (m, 4H,
aromatic Hs), 6.38 (t, 1H, H-10, J=6.5Hz), 5.36 (m, 1H,
H-30), 4.47 (broad, 1H, 30-OH), 4.25–3.90 (m, 5H, H-40,
NCH2 and ethoxy CH2), 3.72 (s, 6H, OCH3), 3.17 (m, 2H,
H-50and H-500), 2.87 (m, 1H, H-20), 2.33 (m, 1H, H-200),
1.17 (t, 3H, CH3, J=6.2Hz).
Synthesis of 50-O-(4,40-dimethoxytrityl)-N
6-
ethoxycarbonylmethyl-20-deoxyadenosine-30-O-
[(2-cyanoethyl)-N,N-diisopropylphosphoramidite] (1c)
To a round bottom ﬂask, which was suspended in an ice
bath and contained a solution of compound 1b (80mg) in
dry CH2Cl2 (5.0ml), was added N,N-diisopropy-
lethylamine (DIEA, 50ml) followed by 2-cyanoethyl-N,N-
diisopropyl chlorophosphoramidite (48ml) (Scheme 2a).
The mixture was stirred at room temperature for 30min
under an argon atmosphere andquenched by adding 0.1ml
CH3OH. The solution was then mixed quickly with
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Scheme 2. Syntheses of phosphoramidite building blocks of ethyl ester derivative of the N
6-CMdA (a) and methyl ester derivative of N
4-CMdC (b).
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saturated NaHCO3 (2.0ml), brine (2.0ml) and dried with
anhydrous Na2SO4. The solvent was evaporated under
reduced pressure to yield ﬁnal product 1c in white foam,
which was used directly for ODN synthesis (72mg; yield;
68%). HRMS (ESI): [M+Na]
+calcd m/z 862.3669, found
862.3678.
31P NMR (80MHz, CDCl3,2 5  C;
Supplementary Figure S6): d 149.8, 149.0.
Synthesis of N
4-methoxycarbonylmethyl-20-
deoxycytidine (2c)
Compound 2b (95mg) was dissolved in 3.0ml of 0.4M
triethylamine in methanol and the solution was stirred at
room temperature for 2 days (Scheme 2b) (25). The
solution was concentrated to a small volume and
co-evaporated with anhydrous methanol (twice) and
toluene (twice) to give white solid (66mg; yield: 92%).
HRMS (ESI): [M+H]
+ calcd m/z 300.1196, found
300.1202.
1H NMR (300MHz, CDCl3,2 5  C;
Supplementary Figure S7): d 8.31 (s, 1H, NH), 7.97
(d, 1H, H-6, J=6.0Hz), 6.25 (t, 1H, H-10, J=7.0Hz),
5.95 (d, 1H, H-5, J=7.5Hz), 4.86 (broad, 2H, 30-OH and
50-OH), 4.36 (m, 1H, H-30), 4.17 (s, 2H, NCH2), 3.93
(m, 1H, H-50), 3.80–3.65 (m, 4H, OCH3 and H-500), 3.32
(m, 1H, H-40), 2.34 (m, 1H, H-200), 2.15 (m, 1H, H-20).
Synthesis of 50-O-(4,40-dimethoxytrityl)-N
4-
methoxycarbonylmethyl-20-deoxycytidine (2d)
This compound was synthesized following the similar pro-
cedures as described for the synthesis of 1b (Scheme 2b).
For the puriﬁcation of this compound, the silica gel
column was ﬁrst washed with CH2Cl2 (with 0.1% TEA)
and the desired compound was eluted from the column
with CH2Cl2/CH3OH (9/1 with 0.1% TEA). Compound
2d was obtained as yellow foam (yield: 74%). HRMS
(ESI): [M+H]
+ calcd m/z 602.2502, found 602.2511.
1H
NMR (300MHz, DMSO-d6,2 5  C; Supplementary
Figure S8): d 8.08 (m, 1H, NH), 7.67 (d, 1H, H-6,
J=6.3Hz), 7.40–7.17 (m, 9H, aromatic Hs), 6.90
(m, 4H, aromatic Hs), 6.13 (t, 1H, H-10, J=6.7Hz), 5.70
(d, 1H, H-5, J=7.5Hz), 5.26 (s, 1H, 30-OH), 4.27 (m, 1H,
H-30), 4.13–4.06 (m, 2H, H-50 and H-500), 3.82 (m, 1H,
H-40), 3.75 (s, 3H, COOCH3), 3.64 (s, 2H, NCH2), 3.32
(m, 6H, OCH3,), 2.20 (m, 1H, H-200), 2.10 (m, 1H, H-20).
Synthesis of 50-O-(4,40-dimethoxytrityl)-N
4-
methoxycarbonylmethyl-20-deoxycytidine-30-O-[(2-
cyanoethyl)-N,N-diisopropylphosphoramidite] (2e)
This compound was synthesized following the similar pro-
cedures as described for the synthesis of 1c (Scheme 2b).
Compound 2e was obtained as white foam, which was
used directly for ODN synthesis without further puriﬁca-
tion (yield: 75%). HRMS (ESI): [M+Na]
+ calcd m/z
824.3400, found 824.3413.
31P NMR (80MHz, CDCl3,
25 C; Supplementary Figure S9): d 150.1, 149.6.
KDA treatment of calf thymus DNA
KDA was prepared through alkaline hydrolysis of ethyl
diazoacetate following previously described procedures
(17,18) and its stock solution (0.8M) was diluted to an
appropriate concentration before usage. Calf thymus
DNA (1.0mg/ml) in PBS buﬀer (pH 7.3) was treated
with freshly prepared KDA solution (10mM) at 37 C
overnight. The resulting DNA was desalted by ethanol
precipitation and the recovered DNA pellets were then
taken up in doubly distilled water and digested with four
enzymes. One unit of nuclease P1, 0.01U of calf spleen
phosphodiesterase, and 2.5ml of buﬀer solution containing
sodium acetate (300mM, pH 5.0) and zinc acetate
(10mM) were added to a 20ml solution of KDA-treated
calf thymus DNA (20mg). The digestion was continued at
37 C for 6h. To the digestion mixture were then added
10U of alkaline phosphatase, 0.05U of snake venom
phosphodiesterase and 5ml of 0.5M Tris–HCl (pH 8.9).
The digestion was continued at 37 C for 6h and the
enzymes were removed by chloroform extraction. The re-
sulting aqueous solution was dried in a Speed-vac and
redissolved in doubly distilled water for LC–MS/MS
analysis.
ODN synthesis
ODNs were synthesized on a Beckman Oligo 1000S DNA
synthesizer (Fullerton, CA, USA) at a 1-mmol scale. The
synthesized phosphoramidite building blocks were
dissolved in anhydrous acetonitrile at a concentration of
0.067M. Standard phosphoramidite building blocks (Glen
Research Inc., Sterling, VA, USA) of dA, dC, dG and dT
were employed and a standard ODN assembly protocol
was used without any modiﬁcation. After synthesis, the
ODN-bearing control pore glass (CPG) beads were ﬁrst
treated with 2.0ml of 0.4M NaOH at room temperature
for 5h and the beads were removed by ﬁltration. The re-
sulting ODN-containing solution was neutralized with
1.0M HCl and the solvent was removed in a Speed-vac.
The residue was then treated with concentrated NH4OH
(3.0ml) at room temperature for 2 days and the solvent
was removed by using Speed-vac. The dried pellet was
reconstituted in water and puriﬁed by HPLC.
In an alternative ODN synthesis protocol, ultra-mild
phosphoramidite building blocks of dA, dC and dG
(Glen Research Inc., Sterling, VA, USA) were used.
After synthesis, the ODN-bearing ultra-mild CPG beads
were suspended in 0.4M NaOH solution (3.0ml) at room
temperature for 5h and the beads were subsequently
removed by ﬁltration. The resulting solution was
neutralized with 1.0M HCl and subjected to HPLC puri-
ﬁcation; HPLC Gradients I and II were used for puriﬁca-
tion of 12-mer and 20-mer ODNs, respectively (ODN
sequences are shown in Table 1).
Enzymatic digestion of synthetic ODNs
A 20-ml solution containing 10 nmol of ODN1 or ODN2
was digested with four enzymes following the same pro-
cedures as described above for the digestion of
KDA-treated calf thymus DNA. The resulting mixtures
were subsequently subjected to HPLC analysis in which
Gradient III was employed.
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The lesion-bearing ODNs (ODN1 or ODN2) and their
complementary strands were dissolved in a 1.1-ml
solution containing NaCl (100mM), sodium phosphate
(10mM, pH 7.0) and EDTA (50mM) at a total ODN con-
centration (Ct) of 1.0, 2.0, 4.0, 8.0 or 16mM. UV absorb-
ance versus temperature proﬁles were recorded on a
Varian Cary 500 spectrophotometer (Varian Inc.) in the
reverse and forward directions for a temperature range of
80–10 C at the rate of 1.0 C/min, and the melting tem-
perature (Tm) value was obtained by the derivative
method. The thermodynamic parameters were obtained
from the van’t Hoﬀ plot (27), in which the reciprocal of
Tm was plotted against ln(Ct/4):
1
Tm
¼
R
H
ln
Ct
4
+
S
H
and equation:
G ¼ H   TS
where R is the universal gas constant (1.987cal
mol
 1K
 1). The error limits for G, H and S
derived from ﬁtted parameters were calculated by using
the previously described equations (28,29).
In vitro replication studies with exonuclease-free Kf
  of
Escherichia coli DNA polymerase I
Primer extension experiments were carried out under
standing-start conditions. The 20-mer lesion-containing
templates and normal templates (50nM) with dA or dC
in lieu of N
6-CMdA or N
4-CMdC were annealed with a
50-[
32P]-labeled 14-mer primer (50nM), to which was
added a mixture of all four dNTPs (100mM each). The
reaction was continued in a 10-ml solution containing
10mM Tris–HCl (pH 7.5), 10mM MgCl2, 50mM NaCl
and 1mM dithiothreitol (DTT) at 37 C for 30min with
diﬀerent amounts of Kf
  added (0, 0.05, 0.1, 0.2 and
0.3U).
In vitro replication experiments were also performed in
the presence of one type of dNTP at a time, where the
concentration for individual dNTP was 1.0mM and 0.1U
of Kf
  was added. The reaction was continued at 37 C for
10min and terminated by adding 8ml of gel-loading
buﬀer, which contained 80% formamide (pH 8.0),
10mM EDTA and 1.0mg/ml each of xylene cyanol and
bromophenol. The products were resolved on 20%
denaturing polyacrylamide gels containing 8M urea. Gel
images were obtained by using a Typhoon 9410 Variable
Mode Imager (Amersham Biosciences Co.) and
ImageQuant 5.2 software (Amersham Biosciences Co.).
RESULTS
Syntheses and structure characterization of N
6-CMdA
and N
4-CMdC
Previous studies have shown that KDA is capable of
inducing O
6-CMdG, N3-CMdT and O
4-CMdT in
isolated DNA (11,18). It remains unexplored what types
of adducts can be induced by KDA at adenine and
cytosine sites in DNA. To examine the diazoacetate-
induced carboxymethylation chemistry of adenine and
cytosine, we ﬁrst developed synthetic strategies for the
preparation of N
6-CMdA and N
4-CMdC (Scheme 1). To
this end, we introduced the ethoxycarbonylmethyl func-
tionality to the N
6 position of 20-deoxyadenosine by sub-
stitution of the chlorine atom in 6-CldA with glycine ethyl
ester (30), and the resulting compound 1a was hydrolyzed
under alkaline conditions to render N
6-CMdA. N
4-CMdC
was synthesized by using a nucleoside conversion strategy
(26). In this context, the 1,2,4-triazolyl moiety in
compound 2a was replaced with glycine ethyl ester to
render compound 2b, which was hydrolyzed under
similar alkaline conditions to yield the desired N
4-CMdC.
Identities of N
6-CMdA and N
4-CMdC were supported
by
1H NMR and HRMS measurements (see ‘Materials
and Methods’ section). Moreover, we employed 2D
heteronuclear multiple-bond correlation (HMBC) experi-
ment to assign unambiguously the sites of
carboxymethylation in these two modiﬁed nucleosides.
In particular, the two methylene protons (at 3.96p.p.m.)
in the carboxymethyl functionality of the N
6-CMdA
exhibit strong correlation with the carboxylic carbon
atom, as well as the C6 atom (at 154p.p.m.), but not the
C2 atom, of the purine ring in a 2D HMBC spectrum
(Supplementary Figure S10a). On the other hand, the cor-
responding methylene protons (at 3.86p.p.m.) of the
N
4-CMdC display strong correlation with the C4 atom
(at 164p.p.m.) of the pyrimidine ring and the carboxylic
carbon (Supplementary Figure S10b). These distinct
spectral features reveal without ambiguity the sites
where the carboxymethyl moiety is introduced.
Formation of N
6-CMdA and N
4-CMdC in calf thymus
DNA upon exposure to KDA
The availability of authentic N
6-CMdA and N
4-CMdC
enabled us to assess whether these two lesions can be
induced in DNA upon diazoacetate treatment. To this
end, we treated calf thymus DNA with potassium
diazoacetate, removed salts from the reaction mixture by
ethanol precipitation, digested the DNA with enzymes
and subjected the resulting nucleoside mixture to LC–
MS/MS analysis, where we monitored selectively the frag-
mentation of the [M+H]
+ ions of the carboxymethylated
derivatives of 20-deoxyadenosine (m/z 310.1) and
20-deoxycytidine (m/z 286.1). The selected-ion chromato-
grams (SICs; Figure 1) for monitoring the neutral loss of
2-deoxyribose (116Da) from the protonated ions of the
two carboxymethylated lesions revealed peaks at 30.5
Table 1. Sequences of synthesized ODNs and the primer used for
in vitro replication experiments
ODNs Sequences
a
ODN1/ODN2 50-ATG GCG XGC TAT-30
ODN3/ODN4 50-ATG GCG XGC TAT GAT CCT AG-30
Primer 50-GCT AGG ATC ATA GC-30
aIn ODN1/ODN3, X=N
6-CMdA and in ODN2/ODN4, X=
N
4-CMdC.
Nucleic Acids Research, 2010,Vol.38, No. 19 6779and 12.2min, respectively (Figure 1b and d). The
product-ion spectra averaged from these two peaks
showed the formation of predominant fragment ions of
m/z 194 and 170 for carboxymethylated 20-deoxyadenosine
and carboxymethylated 20-deoxycytidine, respectively
(Figure 2b and d), which are attributed to arise from the
elimination of a 2-deoxyribose component.
We also subjected standard N
6-CMdA and N
4-CMdC
to LC–MS/MS analysis under the same experimental con-
ditions. It turned out that these two modiﬁed nucleosides
share the same retention times (Figure 1a and c) and iden-
tical product-ion spectra (Figure 2a and c) as the two
components present in the enzymatic digestion mixture
of KDA-treated calf thymus DNA. This result
demonstrated that N
6-CMdA and N
4-CMdC are the
major carboxymethylated lesions of dA and dC, respect-
ively, induced by KDA in calf thymus DNA.
Based on the peak areas found in the SICs for monitor-
ing the neutral loss of 2-deoxyribose from the
carboxymethylated derivatives of all four natural
nucleosides and with the assumption that these
carboxymethylated nucleosides exhibit the same ioniza-
tion and fragmentation eﬃciencies, we estimated that the
amount of N
6-CMdA was approximately 10 times greater
than any other known carboxymethylated nucleosides
(data not shown). In this context, we were also able to
detect N3-CMdT, O
4-CMdT and O
6-CMdG in the same
digestion mixture (18), and it is worth emphasizing that
the accurate quantiﬁcation of these lesions formed in vitro
or in cells requires LC-MS/MS analysis with the use of
stable isotope-labeled forms of the carboxymethylated
nucleosides, and these compounds are currently being
synthesized in our laboratory.
Solid-phase synthesis of ODNs containing site-speciﬁcally
inserted N
6-CMdA and N
4-CMdC
Our experimental data clearly revealed that N
6-CMdA
and N
4-CMdC can be induced in calf thymus DNA
upon exposure to KDA, and ODNs bearing a
site-speciﬁcally incorporated lesion are essential for
future studies about how these lesions perturb DNA rep-
lication and how they are repaired. Therefore, we
extended the above-described synthetic methods to the
preparation of the phosphoramidite building blocks that
allow for the insertion of N
6-CMdA and N
4-CMdC into
ODNs by using automated solid-phase synthesis
(Scheme 2). In this regard, it is worth noting that
previous studies by Harris and coworkers (30) showed
that ODNs containing some N
6-substituted dA derivatives
could be obtained by nucleophilic displacements of
chlorine atom in 6-CldA with amine-containing species.
We attempted to employ a similar approach by
incorporating 6-CldA into an ODN and treating the
ODN with glycine or glycine ethyl ester; however, no ap-
preciable displacement was observed after 3 days. Thus,
we converted compound 1a to its phosphoramidite
building block (1c) and obtained the desired N
6-
CMdA-bearing ODNs via post-oligomerization alkaline
hydrolysis.
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Figure 1. LC–MS/MS for monitoring the formation of N
6-CMdA and
N
4-CMdC in KDA-treated calf thymus DNA. Shown are the SICs for
monitoring the m/z 310.1!194.1 and 286.1!170.1 transition, corres-
ponding to the loss of a 2-deoxyribose, from the LC–MS/MS analyses
with the injection of: (a) N
6-CMdA standard; (b) enzymatic digestion
mixture of calf thymus DNA treated with 10mM of KDA; (c)
N
4-CMdC standard; and (d) the same sample as in (b).
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Figure 2. Collision-induced dissociation (CID) mass spectra supporting
the formation of N
6-CMdA and N
4-CMdC in calf thymus DNA.
Shown are the MS/MS results that monitor the fragmentation of the
protonated-ions of N
6-CMdA (m/z 310.1) and N
4-CMdC (m/z 286.1),
for: (a) standard N
6-CMdA; (b) the 30.5-min fraction shown in Figure
1b; (c) standard N
4-CMdC; and (d) the 12.2-min fraction shown in
Figure 1d.
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block for the methyl ester derivative of N
4-CMdC
(compound 2e) from compound 2b. Removal of two
hydroxyl groups in compound 2b was carried out by treat-
ment with 0.4M TEA in methanol for one day, and in the
mean time, the ethoxycarbonylmethyl moiety on C4 was
converted to methoxycarbonylmethyl moiety (Scheme 2b).
After this step, the phosphoramidite building block 2f can
be readily prepared following standard procedures.
We next incorporated the ester derivatives of N
6-CMdA
and N
4-CMdC into ODNs. After synthesis, the
ODN-bearing CPG beads were ﬁrst treated with 0.4M
NaOH at room temperature for 5h. Upon this treatment,
the ester derivatives of the carboxymethyl functionality
were hydrolyzed to the corresponding carboxylic acid,
the ODNs were cleaved from the CPG beads and the
nucleobase-protecting groups were partially removed.
The complete deprotection of nucleobases was attained
by further treatment with concentrated NH4OH at room
temperature for 2 days. It is worth noting that the above
conversion/deprotection protocol is essential since direct
treatment of the ester precursor-containing ODNs with
concentrated NH4OH, as used in standard ODN
deprotection, gave rise to the facile conversion of the
ester to its corresponding amide (data not shown).
We also developed an alternative ODN synthesis
protocol where ultra-mild phosphoramidite building
blocks were employed. Since the exocyclic amino groups
of dA and dC are conjugated with ethoxy- and
methoxycarbonylmethyl moieties, which simultan-
eously serve as nucleobase protecting groups, the
phosphoramidite building blocks 1c and 2e can therefore
be used directly for ODN assembly. After synthesis, a 5-h
NaOH treatment is suﬃcient for cleavage, deprotection
and ester-to-acid conversion. This strategy totally
obviated the use of NH4OH and it constituted an alterna-
tive protocol for the synthesis of ODNs bearing a
carboxymethylated DNA adduct. The completely
deprotected ODNs were then puriﬁed by HPLC and the
HPLC traces are shown in supporting information
(Supplementary Figures S11–S14).
ESI-MS and MS/MS characterizations of ODNs
containing N
6-CMdA and N
4-CMdC
We next characterized the N
6-CMdA and N
4-
CMdC-carrying ODNs by MS. Here, we use d(ATG
GCG XGC TAT) (ODN1, ‘X’ represents N
6-CMdA) as
an example to illustrate how we use ESI-MS and MS/MS
to conﬁrm the site of N
6-CMdA incorporation.
Negative-ion ESI-MS analysis of this ODN gave a
deconvoluted mass of 3741.8 Da for ODN1 (Figure 3a),
which is 58 Da higher than the calculated mass of the
unmodiﬁed d(ATG GCG AGC TAT) (i.e. 3683.8 Da).
This result is consistent with the presence of an N
6-
CMdA adduct in this substrate. The product-ion
spectrum of the [M-3H]
3  ion (m/z 1246.7) of ODN1
showed the formation of wn ions (Figure 3b): w 
3 ,w  
4 ,
w 
5 ,w  
6 ,w 2 
5 ,w2 
6 ,w2 
7 ,w2 
8 ,w2 
9 and w3 
11 , as well as [an -
Base] ions: [a3 -G ]
 ,[ a 4 -G ]
 ,[ a 5 -C ]
 ,[ a 6 -G ]
 ,
[a7 -X ]
2 ,[ a 8 -G ]
2 ,[ a 9 -C ]
2  and [a11 -A ]
2  ions. The
measured masses for the w3,w 4 and w5 ions were the same
as the calculated masses for the corresponding ions of the
unmodiﬁed ODN, whereas the w6,w 7,w 8,w 9 and w11 ions
exhibited 58 Da higher in mass than the corresponding
fragment ions formed from the unmodiﬁed ODN. These
results are consistent with the presence of an N
6-CMdA at
the seventh position in the ODN. The above ﬁnding is
further supported by the observed masses for the [an -
Base] ions. In this respect, the measured masses for the
[a8- G], [a9- C] and [a11- A] ions are 58 Da higher, whereas
the measured masses of the [a3 - G], [a4 - G], [a5 - C], [a6 -
G] and [a7- X] ions are the same as the calculated ones of
the corresponding fragment ions for the unmodiﬁed
d(ATG GCG AGC TAT). The other sequences were
also conﬁrmed by the similar ESI-MS and MS/MS
analyses (Supplementary Figures S15–S17).
Homogeneity of the lesion-containing ODNs
To further conﬁrm the incorporation of N
6-CMdA and
N
4-CMdC into ODNs, we digested ODN1 and ODN2
into 20-deoxynucleosides, separated the digestion
mixtures by HPLC and veriﬁed each component by
ESI-MS. Indeed, the HPLC traces revealed the presence
of N
6-CMdA in the digestion mixture of ODN1 (the
25.4min fraction; Supplementary Figure S18a) and
N
4-CMdC in the digestion mixture of ODN2 (the
12.6min fraction; Supplementary Figure S18b).
We further integrated the peak areas of dC, dT, dG and
N
6-CMdA or N
4-CMdC in HPLC traces; peak area of dA
was not estimated due to the partial deamination of dA to
Figure 3. ESI-MS and MS/MS characterizations of
d(ATGGCGXGCTAT), X=N
6-CMdA: (a) negative-ion ESI-MS; (b)
product-ion spectrum of the [M-3H]
3  ion (m/z 1246.3).
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present in the commercial preparation of the enzyme(s)
used in DNA digestion. With the consideration of the
molar extinction coeﬃcients of nucleosides at 260nm
[i.e. 12100Lmol
 1cm
 1 and 9300Lmol
 1cm
 1 were
found for N
6-CMdA and N
4-CMdC by using a previous-
ly described method (31)], the molar ratio of
N
6-CMdA:dC:dT:dG turned out to be 1.0:2.1:3.1:4.2
for ODN1, and the molar ratio of N
4-CMdC:dC:dT:dG
for ODN2 was 1.0:2.0:3.0:4.0. These data are consistent
with the presence of one N
6-CMdA or N
4-CMdC, two
dC, three dT and four dG residues in the two ODNs.
Thermodynamic properties of lesion-containing DNA
duplexes
To examine how the presence of N
6-CMdA and
N
4-CMdC aﬀects duplex stability, we determined the
thermodynamic parameters for the formation of duplex
DNA harboring an N
6-CMdA, N
4-CMdC, or unmodi-
ﬁed dA and dC by melting temperature measurements.
The ODN sequences used in this study were ODN1 and
ODN2 (Table 1), and the H and S were calculated
from the intercept and slope found in the van’t Hoﬀ plot
following the equations described in the ‘Materials and
Methods’ section (Supplementary Figure S19). It turned
out that the presence of N
6-CMdA and N
4-CMdC
destabilized the duplex by 5.3 and 6.8kcal/mol in free
energy at 25 C, respectively (Table 2).
In vitro replication studies with Kf
 
We next examined the bypass of N
6-CMdA and
N
4-CMdC with the Kf
  by carrying out in vitro primer
extension assays. To this end, we assessed the ability of the
Kf
  that has been used extensively as a model replicative
polymerase, to extend a 50-[
32P]-labeled 14-mer primer
annealed with the N
6-CMdA- or N
4-CMdC-bearing
20-mer template in the presence of all four dNTPs. The
primer extension results unveiled that N
6-CMdA does not
block substantially the DNA synthesis mediated by Kf
 
and the full-length products can be readily detected.
N
4-CMdC, however, inhibits markedly the DNA synthe-
sis, though a small amount of full-length products could
also be detected. In both cases, synthesis did not stop after
the incorporation of one nucleotide opposite N
6-CMdA or
N
4-CMdC (Figure 4a). When the above primer/template
complex was incubated with Kf
  in the presence of one
type of nucleotide at a time, we found that the correct
nucleotides, dT and dG, are preferentially incorporated
opposite N
6-CMdA and N
4-CMdC, respectively.
However, misincorporation also occurred, that is, Kf
  in-
corporates dAMP opposite N
6-CMdA, and dTMP or
dAMP opposite N
4-CMdC (Figure 4b).
DISCUSSION
Recently, emerging data have shown that exposure to
NOCs and the resultant carboxymethylation of DNA
are signiﬁcantly associated with the risk of developing
non-cardia gastric cancer (2,32). Some earlier studies
(11) along with recent results from our laboratory (18)
suggested that all four nucleosides can be carboxy-
methylated, with the highest yield being observed for
N
6-CMdA (vide supra). Obtaining ODNs bearing a
Table 2. Thermodynamic parameters for duplex formation
Duplex H S G25 C G25 C
(kcal mol
 1) (cal mol
 1K
 1) (kcal mol
 1) (kcal mol
 1)
50-ATGGCGXGCTAT-30
30-TACCGCTCGATA-50
X=dA  101.4±3.3  286±14  16.1±0.4
X=N
6-CMdA  76.7±2.1  221±7  10.8±0.2 5.3
50-ATGGCGXGCTAT-30
30-TACCGCGCGATA-50
X=dC  119.0±3.8  333±16  19.7±0.5
X=N
4-CMdC  78.5±2.5  220±7  12.9±0.2 6.8
G25 C=G25 C (lesion-containing duplex) G25 C (unmodiﬁed duplex).
Figure 4. In vitro replication studies of N
6-CMdA- or N
4-
CMdC-bearing ODNs and the corresponding unmodiﬁed substrates
with Kf
  of E. coli DNA polymerase I. A template,
d(ATGGCGXGCTATGATCCTAG) (‘X’ represents N
6-CMdA, N
4-
CMdC, dA or dC), and a 50-[
32P]-labeled primer,
d(p*GCTAGGATCATAGC), were employed. The concentration of
the resulting duplex ODNs was 50nM. The replication experiments
were carried out: (a) in the presence of all four dNTPs at a concentra-
tion of 1.0mM each for 30min and the amounts of Kf
  are indicated
in the ﬁgure; and (b) in the presence of dNTPs individually
([dNTP]=1.0mM) at 37 C for 10min, and 0.1U of Kf
  was used.
6782 Nucleic Acids Research, 2010,Vol.38, No. 19site-speciﬁcally incorporated carboxymethylated lesion
constitutes a crucial step toward examining the biological
implications of the lesion at the molecular level. Syntheses
of O
6-CMdG-, N3-CMdT- and O
4-CMdT-containing
ODNs were reported previously (12,18). In this study,
we developed facile synthetic strategies for the preparation
of authentic N
6-CMdA and N
4-CMdC, as well as the
phosphoramidite building blocks of their ester derivatives.
The latter compounds facilitate the incorporation of
N
6-CMdA and N
4-CMdC into ODNs at deﬁned sites.
We demonstrated that the method allowed for the prep-
aration of 12- and 20-mer ODNs in reasonably good yield.
We were able to obtain  200nmol of the lesion-bearing
ODNs from a 1-mmol scale synthesis. Together with pre-
viously published synthetic strategy for O
6-CMdG (12,25),
N3-CMdT and O
4-CMdT (18), it can be concluded that
the ester derivatives of carboxymethyl moieties are univer-
sal precursors for the syntheses of phosphoramidite
building blocks for the preparation of ODNs containing
site-speciﬁcally inserted carboxymethylated DNA lesions.
Additionally, the alkaline conditions for the conversion
from ester to acid after oligomerization are compatible
with ODN deprotection protocols.
Thermodynamic parameters for duplex formation, as
derived from melting temperature measurements,
revealed that the introduction of an N
6-CMdA and
N
4-CMdC into duplex DNA led to an increase in G
for duplex formation at 25 C by 5.3 and 6.8kcal/mol,
respectively (Table 2). The increases in G for duplex
formation are much larger than what we observed for
N
2-(1-carboxyethyl)-20-deoxyguanosine (3.8 and 4.0kcal/
mol for the S and R diastereomers, respectively) (33).
The destabilization to a DNA double helix induced by
N
6-CMdA and N
4-CMdC might occur through a signiﬁ-
cant change to local DNA structures. Additionally, the
presence of the carboxymethyl functionality at the N
6
position of adenine and the N
4 position of cytosine may
perturb the tautomeric equilibrium of these nucleobases
thereby destabilizing duplex DNA. Future structural
studies of N
6-CMdA- and N
4-CMdC-bearing duplex
DNA will oﬀer important insights into the substantial de-
stabilization of duplex DNA introduced by these two
lesions.
The primer extension results unveiled that N
6-CMdA
does not block signiﬁcantly the DNA synthesis across
the lesion site mediated by Kf
  and full-length products
can be detected at a relatively high percentage. N
4-CMdC,
however, blocked remarkably the DNA synthesis across
the lesion site although there was a small amount of
full-length products. These results are consistent with
previous studies showing that Kf
  could bypass other
N
6-dA adducts induced by styrene oxide or
benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide (34,35),
whereas little is known about how Kf
  bypasses N
4-dC
adducts.
When the in vitro replication with Kf
  was ﬁrst carried
out in the presence of one type of nucleotide at a time, we
found that, aside from correct nucleotide insertion, Kf
 
incorporated readily the wrong nucleotides, dAMP,
opposite N
6-CMdA, and the enzyme also induced the
misinsertion of dAMP and dTMP opposite N
4-CMdC.
This ﬁnding is consistent with results from a previous
shuttle vector study showing that KDA induces
GC!TA and AT!TA transversions and GC!AT tran-
sitions in a p53 gene (17). Future steady-state kinetic
measurements for nucleotide incorporation opposite and
beyond the lesion sites and studies on how N
6-CMdA and
N
4-CMdC perturb DNA replication in vivo will aﬀord
more insights into the biological implications of these
carboxymethylated lesions, and the availabilities of the
lesion-containing substrates render such studies possible.
Some initial repair studies have been carried out for O
6-
CMdG, and it was found that the azaserine-mediated cell
killing cannot be rescued by the overexpression of
O
6-methylguanine methyltransferase (MGMT) (36),
which is in line with the observation that O
6-CMdG is
not subjected to repair by MGMT in vitro (11). On the
other hand, lymphoblastoid cells deﬁcient in nucleotide
excision repair (NER) were signiﬁcantly more sensitive
to azaserine than the control repair-proﬁcient cells, sug-
gesting that some azaserine-induced DNA lesions can be
repaired by NER factors (36). The availability of the
N
6-CMdA- and N
4-CMdC-carrying substrates also facili-
tates the future investigations about how these lesions are
repaired.
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